Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gabriella Fabbrocini and Giovanni Pellacani.
Gabriella Fabbrocini
Connection Strength
0.178
Giovanni Pellacani
  1. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
    View in: PubMed
    Score: 0.060
  2. Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
    View in: PubMed
    Score: 0.060
  3. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.